Back to top
more

Gilead Sciences, Inc. (GILD)

(Real Time Quote from BATS)

$80.91 USD

80.91
5,278,642

+1.42 (1.79%)

Updated Feb 23, 2018 03:58 PM ET

Add to portfolio

4-Sell       4  

A Value | D Growth | C Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for GILD

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Gilead Sciences, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Assets          
Cash & Equivalents 36,694 11,895 14,607 10,128 2,132
Receivables 3,851 4,514 5,854 4,635 2,100
Notes Receivable NA 0 0 0 0
Inventories 801 1,587 1,955 1,386 2,056
Other Current Assets NA 2,449 2,347 1,565 986
Total Current Assets 41,346 20,445 24,763 17,714 7,274
Net Property & Equipment 3,295 2,865 2,276 1,674 1,166
Investments & Advances NA 20,485 11,601 1,598 439
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 402 324 236 155
Intangibles 21,259 10,143 11,419 12,245 13,069
Deposits & Other Assets 4,383 2,637 1,456 1,197 394
Total Assets 70,283 56,977 51,839 34,664 22,497
Liabilities & Shareholders Equity 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Notes Payable NA 0 0 0 0
Accounts Payable NA 1,206 1,178 955 1,256
Current Portion Long-Term Debt NA 0 983 483 2,697
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 7,811 7,290 4,084 2,251
Income Taxes Payable NA 0 0 105 11
Other Current Liabilities NA 202 440 134 111
Total Current Liabilities 11,635 9,219 9,891 5,761 6,325
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 51 105
Convertible Debt NA 0 2 15 64
Long-Term Debt NA 26,642 21,590 11,921 4,095
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities 38,147 1,753 1,243 1,097 162
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities 49,782 37,614 32,726 18,845 10,752
Shareholders Equity 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 2 2
Capital Surplus NA 454 444 2,391 5,387
Retained Earnings NA 18,154 18,001 12,732 6,105
Other Equity NA 754 667 694 251
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity 20,501 19,363 19,113 15,819 11,745
Total Liabilities & Shareholder's Equity 70,283 56,977 51,839 34,664 22,497
Total Common Equity 120,500 19,363 19,113 15,819 11,745
Shares Outstanding 1,306.20 1,317.40 1,441.10 1,508.60 1,533.30
Book Value Per Share 92.25 14.70 13.26 10.49 7.66

Fiscal Year End for Gilead Sciences, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Assets          
Cash & Equivalents 36,694 28,387 21,096 14,115 11,895
Receivables 3,851 4,122 4,478 4,034 4,514
Notes Receivable NA 0 0 0 0
Inventories 801 1,144 1,408 1,474 1,587
Other Current Assets NA 1,664 1,610 1,801 2,449
Total Current Assets 41,346 35,317 28,592 21,424 20,445
Net Property & Equipment 3,295 3,100 3,012 2,922 2,865
Investments & Advances NA 12,973 15,480 19,902 20,485
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 1,147 1,137 1,208 402
Intangibles 21,259 9,514 9,723 9,933 10,143
Deposits & Other Assets 4,383 2,611 2,319 2,312 2,637
Total Assets 70,283 64,662 60,263 57,701 56,977
Liabilities & Shareholders Equity 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Notes Payable NA 0 0 0 0
Accounts Payable NA 696 819 944 1,206
Current Portion Long-Term Debt NA 1,747 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 7,154 7,673 7,338 7,811
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 202
Total Current Liabilities 11,635 9,597 8,492 8,282 9,219
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 27,774 26,738 26,321 26,642
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities 38,147 1,942 2,181 1,753
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities 49,782 39,408 37,172 36,784 37,614
Shareholders Equity 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 906 733 616 454
Retained Earnings NA 23,689 21,823 19,564 18,154
Other Equity NA 658 534 736 754
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity 20,501 25,254 23,091 20,917 19,363
Total Liabilities & Shareholder's Equity 70,283 64,662 60,263 57,701 56,977
Total Common Equity 120,500 25,254 23,091 20,917 19,363
Shares Outstanding 1,306.20 1,307.00 1,306.00 1,307.20 1,317.40
Book Value Per Share 92.25 19.32 17.68 16.00 14.70